Market Cap

Psychemedics Corporation Market Capitalization:

$14.7 Million

USD as of July 1, 2025

business Psychemedics Corporation Company Profile

Psychemedics Corporation Main Stock Listing

NASDAQ: PMD

Market Capitalization History of Psychemedics Corporation

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Diagnostics & Research
Company Market Cap (USD)
Thermo Fisher Scientific $162.07 B
Danaher $144.92 B
Siemens Healthineers AG $64.17 B
Lonza Group Ltd $49.67 B
IDEXX Laboratories, Inc. $43.99 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Yearly evolution of Psychemedics Corporation market cap

Date Market Cap YoY Change
Jan. 1, 2024 $21.8 M -30.73%
Jan. 1, 2023 $31.4 M -22.24%
Jan. 1, 2022 $40.4 M 5.15%
Jan. 1, 2021 $38.4 M -28.42%
Jan. 1, 2020 $53.7 M -47.69%
Jan. 1, 2019 $102.6 M -9.25%
Jan. 1, 2018 $113.0 M 6.04%
Jan. 1, 2017 $106.6 M 100.96%
Jan. 1, 2016 $53.0 M -37.23%
Jan. 1, 2015 $84.5 M -2.29%
Jan. 1, 2014 $86.5 M 28.33%
Jan. 1, 2013 $67.4 M 22.74%
Jan. 1, 2012 $54.9 M 15.30%
Jan. 1, 2011 $47.6 M 9.34%
Jan. 1, 2010 $43.6 M 12.88%
Jan. 1, 2009 $38.6 M -59.71%
Jan. 1, 2008 $95.8 M -9.12%
Jan. 1, 2007 $105.4 M 27.74%
Jan. 1, 2006 $82.5 M 12.31%
Jan. 1, 2005 $73.4 M 7.00%
Jan. 1, 2004 $68.6 M 31.78%
Jan. 1, 2003 $52.1 M -40.90%
Jan. 1, 2002 $88.1 M -22.77%
Jan. 1, 2001 $114.1 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Psychemedics Corporation Categories

United States languages Healthcare languages Diagnostics & Research
United States Healthcare United States Diagnostics & Research

Stocks & Indices

Psychemedics Corporation has the following listings and related stock indices.


Stock: NASDAQ: PMD

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.